Numerous clinical trials are ongoing to test the efficacy and safety of stem cell treatments for neonatal disorders. For example, trials are exploring the use of umbilical cord blood stem cells to treat conditions like hypoxic-ischemic encephalopathy and bronchopulmonary dysplasia. The results so far are promising but more research is needed before these treatments become widely available.